NFKB1 and type 2 diabetes mellitus: These results indicate that in prostate samples of patients with T2D, the higher AKR1C transcript levels may elevate the synthesis of bioactive prostaglandins, which, in turn, could induce the NFκB-inflammatory processes that lead to accelerated tumor progression (Figure 5).